The Nicotine Litigation Wave, Round Two: Why the Vape Industry Is Facing Its Big Tobacco Moment

The legal complaint reads like a replay of the 1990s: the defendant marketed an addictive product to young people, concealed the health risks, and denied the addiction potential until the evidence became undeniable. But the defendant is not Philip Morris. It's Juul Labs—the startup that transformed vaping from a niche hobby into a cultural phenomenon and then watched its market share collapse under the weight of litigation, regulation, and public backlash. The plaintiffs are not state attorneys general (though they're involved too). They are school districts, individual consumers, and class-action law firms that have discovered that the legal theories that brought down Big Tobacco apply with equal force to the vaping industry. **The nicotine litigation wave, round two, is underway—and it will reshape the industry more than any regulation ever could.**

**The legal theories are adapted from the tobacco litigation playbook** but applied to a different set of facts. Claims against Juul and other vaping companies include: defective design (the high-nicotine-salt formulation made the products unreasonably addictive), failure to warn (the company did not adequately disclose the addiction risk), marketing to youth (social media influencers, flavored products, youth-oriented advertising), and public nuisance (the costs of addressing youth vaping in schools). These are the same claims that succeeded against the cigarette industry. **The difference is the product: cigarettes kill their users through combustion-related disease; vaping products, by the best available evidence, do not. The legal system's binary framework—a product is either 'safe' or 'defective'—is being applied to products that exist on a continuum of risk, with consequences that the framework was not designed to handle.**

**The litigation is producing settlements that are reshaping the industry's economics.** Juul has already paid over $2 billion to settle claims from states, school districts, and individual plaintiffs. The settlements have forced the company to restructure, divest, and dramatically scale back its operations. The financial pressure has been compounded by the FDA's regulatory actions (the marketing denial order, subsequently stayed) and the collapse of Juul's market share as consumers shifted to disposable products. **Juul, once the most valuable private company in Silicon Valley, valued at $38 billion at the time of Altria's investment in 2018, is now fighting for survival. The litigation wave that began with Juul is spreading to other vaping companies—and the legal theories that succeeded against Juul are generalizable to any nicotine product that is marketed in ways that appeal to youth and that delivers nicotine efficiently.**

**The public health implications are deeply ambiguous.** The litigation is holding the vaping industry accountable for marketing practices that, by any reasonable standard, contributed to youth nicotine initiation—a public health benefit. But the litigation is also imposing costs on the industry that will be passed on to consumers in the form of higher prices, reduced product availability, and—potentially—the elimination of products that adult smokers rely on to stay off cigarettes. **The litigation that punishes companies for marketing to youth may, inadvertently, restrict the availability of the most effective smoking-cessation tool ever invented for the adult smokers who need it. The legal system, designed to deliver justice between parties, is not designed to optimize population health—and the tension between legal accountability and public health impact is unresolved.**

**The historical parallel is cautionary.** The Master Settlement Agreement of 1998, which resolved the state attorneys general lawsuits against the cigarette industry, produced public health benefits (marketing restrictions, funding for tobacco control programs) and public health harms (the financialization of cigarette revenue that made states dependent on continued smoking). The MSA was not designed by public health experts. It was designed by lawyers—and its legacy is complex. **The vaping litigation wave will produce a similar legacy: a settlement structure that provides compensation for past harm (to states, schools, and individuals) while creating incentives that shape the future of the nicotine market in ways that are difficult to predict and impossible to control. The courts, not the regulators, are designing the future of the nicotine industry—and the future they're designing may not be the future that public health would choose.**

**💬 Do you think the vaping industry deserves the litigation it's facing—or is the legal system punishing companies for creating products that, whatever their marketing failures, have helped millions of smokers quit?** Is there a way to hold companies accountable for youth marketing without destroying the products that adult smokers depend on?